Papillary thyroid cancer medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 20: | Line 20: | ||
|- | |- | ||
|} | |} | ||
=== | ===Thyroid-suppression therapy=== | ||
* | * [[TSH]] suppression with [[thyroxine]] is effective in many [[lesions]] that are not sensitive to 131I. | ||
===Targeted therapy=== | |||
=== | * This type of treatment is done using: | ||
* Sorafenib | ** [[Sorafenib]], an Sorafenib is an orally active, multityrosine kinase inhibitor. | ||
* Lenvatinib | ** [[Lenvatinib]], an orally active, multitargeted tyrosine kinase inhibitor. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 19:40, 14 August 2019
|
Papillary thyroid cancer Microchapters |
|
Differentiating Papillary thyroid cancer from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Papillary thyroid cancer medical therapy On the Web |
|
American Roentgen Ray Society Images of Papillary thyroid cancer medical therapy |
|
Risk calculators and risk factors for Papillary thyroid cancer medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2] Ammu Susheela, M.D. [3]
Overview
Patients with papillary thyroid cancer are treated with radioactive iodine therapy, hormone therapy, and targeted medical therapy.
Medical Therapy
- Treatment options for papillary thyroid cancer include:[1]
| Papillary thyroid cnacer treatment | |||||||||||||||||||||||||||||||||||||
| Localized or regional tumor | Metastatic | Recurrent | |||||||||||||||||||||||||||||||||||
| Surgery Total thyroidectomy Lobectomy RAI therapy Thyroid suppression therapy EBRT | Surgery ± postoperative RAI therapy Targeted therapy EBRT Chemotherapy | ||||||||||||||||||||||||||||||||||||
| Iodine sensitive | Iodine resistent | ||||||||||||||||||||||||||||||||||||
| RAI therapy Thyroid suppression therapy | Thyroid suppression therapy Targeted therapy Surgery EBRT | ||||||||||||||||||||||||||||||||||||
| Papillary Thyroid Cancer Treatment Options |
|---|
Thyroid-suppression therapy
Targeted therapy
- This type of treatment is done using:
- Sorafenib, an Sorafenib is an orally active, multityrosine kinase inhibitor.
- Lenvatinib, an orally active, multitargeted tyrosine kinase inhibitor.